English

Medytox Solutions, Inc.

EDGAR

Quarterly report (10-Q) · filed 2015-08-14

37 filing records in this dataset, filed from 2009-04-06 to 2015-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

13.2 million USD

2015 Q2 · USD

Exact inputs and evidence

Revenue: 13225117 USD Source

Operating margin

-34.72%

2015 Q2 · %

Exact inputs and evidence

Operating Income: -4591708 USD Source
Revenue: 13225117 USD Source

Operating cash flow

1.23 million USD

2015 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -2558374 USD Source
Operating Cash Flow: -3791233 USD Source

Free cash flow

1.12 million USD

2015 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -2558374 USD Source
Operating Cash Flow: -3791233 USD Source
Capital Expenditure: 324750 USD Source
Capital Expenditure: 213142 USD Source

Cash and cash equivalents: 97.1 thousand Unit2 2011-12-31 Source
Exact value

97103 Unit2
Long-term debt including current maturities: 259 thousand USD 2015-06-30 Source
Exact value

259184 USD
Shares outstanding: 30.9 million shares 2015-06-30 Source
Exact value

30931026 shares

Reported share-count change

2.15% · 650 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

30281386 shares · 2014-06-30· Source
30931026 shares · 2015-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

1.9 million USD

2014-07-01 – 2015-06-30

Exact inputs and evidence

Capital expenditure: 1417979 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 920024 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 2491567 USD · 2014-01-01 – 2014-12-31 Source
Capital expenditure: 1417979 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 213142 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 324750 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 213142 USD · 2015-01-01 – 2015-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-08-14.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2014-12-31
Operating income: 3 of 11 periods available· newest 2014-12-31
Net income: 4 of 11 periods available· newest 2014-12-31
Operating cash flow: 3 of 11 periods available· newest 2014-12-31
Capital expenditure: 3 of 11 periods available· newest 2014-12-31
Total assets: 4 of 11 periods available· newest 2014-12-31
Total liabilities: 4 of 11 periods available· newest 2014-12-31
Current assets: 4 of 11 periods available· newest 2014-12-31
Current liabilities: 4 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2011-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2014-12-31
Shares outstanding: 3 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+47%

Prior period

USD 52.52 million

2013-01-01 – 2013-12-31
Current period

USD 77.22 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

77223964 − 52523660 = 24700304 USD

52523660 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
77223964 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Year-over-year change in Revenue: 24700304 USD Concept: fundies:Revenue Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 77223964 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#468089 Filing: 000101968715001458 Input fundies:Revenue: 52523660 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#468206 Filing: 000101968715001458
The citation records this snapshot. The page link may show a newer release later.
Net income
-50.3%

Prior period

USD 5.66 million

2013-01-01 – 2013-12-31
Current period

USD 2.81 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

2810032 − 5658619 = -2848587 USD

5658619 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
2810032 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Year-over-year change in Net income: -2848587 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 2810032 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#144710 Filing: 000101968715001458 Input fundies:NetIncome: 5658619 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#144836 Filing: 000101968715001458
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-2.5%

Prior period

USD 8.46 million

2013-01-01 – 2013-12-31
Current period

USD 8.25 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

8254275 − 8462481 = -208206 USD

8462481 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
8254275 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Year-over-year change in Operating cash flow: -208206 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 8254275 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164281 Filing: 000101968715001458 Input fundies:OperatingCashFlow: 8462481 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164465 Filing: 000101968715001458
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+127%

Prior period

USD 1.1 million

2013-01-01 – 2013-12-31
Current period

USD 2.49 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

2491567 − 1097766 = 1393801 USD

1097766 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
2491567 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Year-over-year change in Capital expenditure: 1393801 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2491567 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164649 Filing: 000101968715001458 Input fundies:CapitalExpenditure: 1097766 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164833 Filing: 000101968715001458
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2014-01-01 – 2014-12-31

Revenue USD 77.22 million 100% of revenue
Cost of revenue USD 15.92 million 21% of revenue
Operating expenses USD 42.27 million 55% of revenue
Other operating costs Derived USD 3.38 million 4.4% of revenue
Operating income USD 15.65 million 20% of revenue
Tax, interest and other Derived USD 12.84 million 17% of revenue
Net income USD 2.81 million 3.6% of revenue

Cash

Operating cash flow USD 8.25 million 11% of revenue
Capital expenditure USD 2.49 million 3.2% of revenue
Free cash flow Derived USD 5.76 million 7.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2011 Not shown: operating income or net income is not reported.
2012 11%83%
2013 11%17%72%
2014 17%80%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2011 2011-01-01 – 2011-12-31	3992652	Unavailable	Unavailable	Unavailable	586795	Unavailable	Source 2011-01-01 – 2011-12-31: 3992652 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 586795 USD Inspect Net Income Open source
2012 2012-01-01 – 2012-12-31	21076357	17545404 Derived	3530953	1231916 Derived	2299037	1512502 Derived	Source 2012-01-01 – 2012-12-31: 21076357 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 3530953 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 2299037 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 2004047 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 491545 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	52523660	38023670 Derived	14499990	8841371 Derived	5658619	7364715 Derived	Source 2013-01-01 – 2013-12-31: 52523660 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 14499990 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 5658619 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 8462481 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 1097766 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	77223964	61568970 Derived	15654994	12844962 Derived	2810032	5762708 Derived	Source 2014-01-01 – 2014-12-31: 77223964 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 15654994 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 2810032 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 8254275 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 2491567 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 77.2M 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Revenue	3992652	Revenue: 3992652 Open source
20122012-12-31	Revenue	21076357	Revenue: 21076357 Open source
20132013-12-31	Revenue	52523660	Revenue: 52523660 Open source
20142014-12-31	Revenue	77223964	Revenue: 77223964 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

47% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Year over year	No prior comparable period	Revenue: 3992652 Open source
20122012-12-31	Year over year	427.9%	Revenue: 21076357 Open source Revenue: 3992652 Open source
20132013-12-31	Year over year	149.2%	Revenue: 52523660 Open source Revenue: 21076357 Open source
20142014-12-31	Year over year	47%	Revenue: 77223964 Open source Revenue: 52523660 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 20.3% 2014

Net margin 3.6% 2014

Free cash flow margin 7.5% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2011-12-31	Operating margin	Not reported	Revenue: 3992652 Open source
20122012-12-31	Operating margin	16.8%	Operating Income: 3530953 Open source Revenue: 21076357 Open source
20132013-12-31	Operating margin	27.6%	Operating Income: 14499990 Open source Revenue: 52523660 Open source
20142014-12-31	Operating margin	20.3%	Operating Income: 15654994 Open source Revenue: 77223964 Open source
20112011-12-31	Net margin	14.7%	Net Income: 586795 Open source Revenue: 3992652 Open source
20122012-12-31	Net margin	10.9%	Net Income: 2299037 Open source Revenue: 21076357 Open source
20132013-12-31	Net margin	10.8%	Net Income: 5658619 Open source Revenue: 52523660 Open source
20142014-12-31	Net margin	3.6%	Net Income: 2810032 Open source Revenue: 77223964 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 3992652 Open source
20122012-12-31	Free cash flow margin	7.2%	Revenue: 21076357 Open source Operating Cash Flow: 2004047 Open source Capital Expenditure: 491545 Open source
20132013-12-31	Free cash flow margin	14%	Revenue: 52523660 Open source Operating Cash Flow: 8462481 Open source Capital Expenditure: 1097766 Open source
20142014-12-31	Free cash flow margin	7.5%	Revenue: 77223964 Open source Operating Cash Flow: 8254275 Open source Capital Expenditure: 2491567 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 8.3M 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Operating cash flow	Not reported	No source recorded
20122012-12-31	Operating cash flow	2004047	Operating Cash Flow: 2004047 Open source
20132013-12-31	Operating cash flow	8462481	Operating Cash Flow: 8462481 Open source
20142014-12-31	Operating cash flow	8254275	Operating Cash Flow: 8254275 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 5.8M 2014

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Free cash flow	Unavailable	No source recorded
20122012-12-31	Free cash flow	1512502	Operating Cash Flow: 2004047 Open source Capital Expenditure: 491545 Open source
20132013-12-31	Free cash flow	7364715	Operating Cash Flow: 8462481 Open source Capital Expenditure: 1097766 Open source
20142014-12-31	Free cash flow	5762708	Operating Cash Flow: 8254275 Open source Capital Expenditure: 2491567 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

57.9% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Liabilities / assets	130.4%	Total Liabilities: 5127701 Open source Total Assets: 3933080 Open source
20122012-12-31	Liabilities / assets	83.1%	Total Liabilities: 9013835 Open source Total Assets: 10848271 Open source
20132013-12-31	Liabilities / assets	65.4%	Total Liabilities: 16538844 Open source Total Assets: 25308057 Open source
20142014-12-31	Liabilities / assets	57.9%	Total Liabilities: 20716930 Open source Total Assets: 35760754 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.12× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Current assets / current liabilities	0.66×	Current Assets: 2465230 Open source Current Liabilities: 3762155 Open source
20122012-12-31	Current assets / current liabilities	0.96×	Current Assets: 8578250 Open source Current Liabilities: 8977735 Open source
20132013-12-31	Current assets / current liabilities	1.15×	Current Assets: 18438317 Open source Current Liabilities: 16049219 Open source
20142014-12-31	Current assets / current liabilities	1.12×	Current Assets: 20328721 Open source Current Liabilities: 18148013 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2011 2011-01-01 – 2011-12-31	USD 586,795 Exact value Exact value: 586795 USD 2011-01-01 – 2011-12-31: 586795 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medytox Solutions, Inc. · 2011-12-31 Medytox Solutions, Inc. (edgar:1374536) Net Income: 586795 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 586795 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000137453613000014/msi-20121231.xml#10791 Filing: 000137453613000014 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	USD 2.3 million Exact value Exact value: 2299037 USD 2012-01-01 – 2012-12-31: 2299037 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medytox Solutions, Inc. · 2012-12-31 Medytox Solutions, Inc. (edgar:1374536) Net Income: 2299037 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2299037 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968714001142/mmms-20131231.xml#130790 Filing: 000101968714001142 The citation records this snapshot. The page link may show a newer release later.	USD 2 million Exact value Exact value: 2004047 USD 2012-01-01 – 2012-12-31: 2004047 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medytox Solutions, Inc. · 2012-12-31 Medytox Solutions, Inc. (edgar:1374536) Operating Cash Flow: 2004047 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2004047 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968714001142/mmms-20131231.xml#145265 Filing: 000101968714001142 The citation records this snapshot. The page link may show a newer release later.	USD 491,545 Exact value Exact value: 491545 USD 2012-01-01 – 2012-12-31: 491545 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medytox Solutions, Inc. · 2012-12-31 Medytox Solutions, Inc. (edgar:1374536) Capital Expenditure: 491545 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 491545 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968714001142/mmms-20131231.xml#150550 Filing: 000101968714001142 The citation records this snapshot. The page link may show a newer release later.	USD 1.51 million Calculation and evidence 2004047 − 491545 USD Exact free cash flow: 1512502 USD 2012-01-01 – 2012-12-31: 2004047 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 491545 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medytox Solutions, Inc. · 2012-12-31 Medytox Solutions, Inc. (edgar:1374536) Free cash flow: 1512502 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2004047 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968714001142/mmms-20131231.xml#145265 Filing: 000101968714001142 Input fundies:CapitalExpenditure: 491545 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968714001142/mmms-20131231.xml#150550 Filing: 000101968714001142 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 5.66 million Exact value Exact value: 5658619 USD 2013-01-01 – 2013-12-31: 5658619 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medytox Solutions, Inc. · 2013-12-31 Medytox Solutions, Inc. (edgar:1374536) Net Income: 5658619 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5658619 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#144836 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.	USD 8.46 million Exact value Exact value: 8462481 USD 2013-01-01 – 2013-12-31: 8462481 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medytox Solutions, Inc. · 2013-12-31 Medytox Solutions, Inc. (edgar:1374536) Operating Cash Flow: 8462481 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8462481 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164465 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.	USD 1.1 million Exact value Exact value: 1097766 USD 2013-01-01 – 2013-12-31: 1097766 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medytox Solutions, Inc. · 2013-12-31 Medytox Solutions, Inc. (edgar:1374536) Capital Expenditure: 1097766 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1097766 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164833 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.	USD 7.36 million Calculation and evidence 8462481 − 1097766 USD Exact free cash flow: 7364715 USD 2013-01-01 – 2013-12-31: 8462481 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1097766 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medytox Solutions, Inc. · 2013-12-31 Medytox Solutions, Inc. (edgar:1374536) Free cash flow: 7364715 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8462481 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164465 Filing: 000101968715001458 Input fundies:CapitalExpenditure: 1097766 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164833 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 2.81 million Exact value Exact value: 2810032 USD 2014-01-01 – 2014-12-31: 2810032 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Net Income: 2810032 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2810032 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#144710 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.	USD 8.25 million Exact value Exact value: 8254275 USD 2014-01-01 – 2014-12-31: 8254275 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Operating Cash Flow: 8254275 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8254275 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164281 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.	USD 2.49 million Exact value Exact value: 2491567 USD 2014-01-01 – 2014-12-31: 2491567 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Capital Expenditure: 2491567 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2491567 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164649 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.	USD 5.76 million Calculation and evidence 8254275 − 2491567 USD Exact free cash flow: 5762708 USD 2014-01-01 – 2014-12-31: 8254275 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 2491567 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medytox Solutions, Inc. · 2014-12-31 Medytox Solutions, Inc. (edgar:1374536) Free cash flow: 5762708 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1374536?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8254275 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164281 Filing: 000101968715001458 Input fundies:CapitalExpenditure: 2491567 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1374536/000101968715001458/mmms-20141231.xml#164649 Filing: 000101968715001458 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

37 filings · 1,267 latest values · 1,267 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001374536, 1374536, edgar:1374536

Also known as CASINO PLAYERS, INC., Medytox Solutions, Inc.

Medytox Solutions, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2014 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation